Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice

In Vivo

Volumn 18, Issue 1, 2004, Pages 55-62

  Zheng, Guodong ^a   Sayama, Kazutoshi ^a   Okubo, Tsutomu ^b   Juneja, Lekh Raj ^b   Oguni, Itaro ^c  

^a SHIZUOKA UNIVERSITY   (Japan)

^b TAIYO KAGAKU CO LTD   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Anti obesity; Caffeine; Catechins; Fat accumulation; Green tea powder; Lipid metabolism; Theanine

Indexed keywords

ANTIOBESITY AGENT; CAFFEINE; CATECHIN; FATTY ACID; GREEN TEA EXTRACT; LIPID; THEANINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN SIZE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; FOOD INTAKE; HYPOPHYSIS; KIDNEY MASS; KIDNEY PARENCHYMA; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID STORAGE; LIVER WEIGHT; MOUSE; MOUSE STRAIN; NONHUMAN; OBESITY; PERITONEUM; SPLEEN WEIGHT; TEA; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 1342304952     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Okuda T, Mori K and Hayatsu H: Inhibitory effect of tannins on direct-acting mutation. Chem Pharm Bull 32: 3755-3758, 1984.
2. Oguni I, Nasu K, Kanaya S, Ota Y, Yamamoto S and Nomura T: Epidemiological and experimental studies on the antitumor activity by green tea extract. Jpn J Nutr 47: 93-102, 1989.
3. Hara Y, Matsuzaki S and Nakamura K: Anti-tumor activity of green tea catechins. J Jpn Soc Nutr Food Sci 42: 39-45, 1989.
4. Valcic S, Timmermann BN, Aiberts DS, Wachter GA, Krutzsch M, Wymer J and Guillen JM: Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anti-cancer Drugs 7: 461-468, 1996.
5. Matsuzaki T and Hara Y: Antioxidative activity of tea leaf catechins. Nippon Nogeikagaku Kaishi 59: 129-134, 1985.
6. Ahmad N, Fayes DK, Nieminen AL, Agarwal R and Mukhtar H: Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Nat Cancer Inst 89: 1881-1889, 1997.
7. Cao Y and Cao R: Angiogenesis inhibited by drinking tea. Nature 398: 1999, 1999.
8. Kono S, Shinchi K, Wakabayashi K, Honjo S, Todoroki I, Sakurai Y, Imanishi K, Nishizawa H, Ogawa S and Katsurada M: Relation of green tea consumption to serum lipids and lipoproteins in Japanese men. J Epidemiol 6: 128-133, 1996.
9. Sayama K, Lin S, Zheng G and Oguni I: Effects of green tea on growth, food utilization and lipid metabolism in mice. In Vivo 14: 481-484, 2000.
10. Takeo T: Green and semi-fermented teas. In: Willson KC and Clifford MN (ed), Tea: Cultivation to Consumption, Chapman and Hall, London and Tokyo, pp.413-457, 1992.
11. Muramatsu K, Fukuyo M and Hara Y: Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol 32: 613-622, 1986.
12. Fukuyo M, Hara Y and Muramatsu K: Effect of tea leaf catechin, (-)-epigallocatechin gallate, on plasma cholesterol level in rats. J Jpn Soc Nutr Food Sci 39: 495-500, 1986.
13. Ikeda I, Imasato Y, Sasaki E, Nakayama M, Nagano H, Takeo T, Yayabe F and Sugano M: Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochem Biophys Acta 1127: 141-146, 1992.
14. Watanabe J, Kawabata J and Niki R: Isolation and identification of acetyl-CoA carboxylase inhibitors from green tea (Camellia sinensis). Biosci Biotechnol Biochem 62: 532-534, 1998.
15. Kao YH, Hiipakka RA and Liao S: Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141: 980-987, 2000.
16. Kao YH, Hiipakka RA and Liao S: Modulation of obesity by a green tea catechin. Am J Clin Nutr 72: 1232-1234, 2000.
17. Han LK, Takaku T, Li J, Kimura Y and Okuda H: Anti-obesity action of oolong tea. Int J Obes 23: 98-105, 1999.
18. Rumpler W, Seale J, Clevidence B, Judd J, Wiley E, Yamamoto S, Komatsu T, Sawaki T, Ishikura Y and Hosoda K: Oolong tea increases metabolic rate and fat oxidation in men. J Nutr 131: 2848-2852, 2001.
19. Racotta IS, Leblanc J and Richard D: The effect of caffeine on food intake in rats: Involvement of corticotropin-releasing factor and the sympatho-adrenal system. Pharm Biochem Behav 48: 887-892, 1994.
20. Dulloo AG, Geissler CA, Horton T, Clooins A and Miller DS: Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr 49: 44-50, 1989.
21. Dulloo AG, Seydoux J, Girardier L, Chantre P and Vandermander J: Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes 24: 252-258, 2000.
22. Kobayashi K, Nagato Y, Aoi N, Juneja LR, Kim M, Yamamoto T and Sugimoto S: Effects of L-theanine on the release of α-brain waves in human volunteers. Nippon Nogeikagaku Kaishi 72: 153-157, 1998.
23. Yokogoshi H, Kobayashi M, Mochizuki M and Terashima T: Effect of theanine, γ-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res 23: 667-673, 1998.
24. Kakuda T, Nozawa A, Unno T, Okamura N and Okai O: Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rat. Biosci Biotechnol Biochem 64: 287-293, 2000.
25. Folch J, Lees M and Sloane-Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 479-509, 1957.
26. Zak B: Simple rapid microtechnic for serum total cholesterol. Am J Clin Pathol 27: 583-588, 1957.
27. Fletcher MJ: A colorimetric method for estimating serum triglycerides. Clin Chim Acta 22: 393-397, 1968.
28. Bartlett GR: Phosphorus assay in column chromatography. J Biol Chem 234: 466-468, 1959.
29. Jung RT, Shetty PS, Jame WPT, Barrand MA and Callingham BA: Caffeine: its effect on catecholamine and metabolism in lean and obese humans. Clin Sci 60: 527-535, 1981.
30. Arciero PJ, Gradner AW, Calles-Escandon J, Benowitz NL and Poehlman ET: Effects of caffeine ingestion on NE kinetics, fat oxidation, and energy expenditure in younger and older men. Am J Physiol 268: E1192-1198, 1995.
31. Robertson D, Frolich JC, Carr RK, Watson JT, Hollifield JW, Shand DG and Oates JA: Effects of caffeine on plasma rennin activity, catecholamines and blood pressure. N Engl J Med 298: 181-186, 1978.
32. Dulloo AG, Seydoux J and Girardier L: Potentiation of the thermogenic antiobesity effects of ephedrine by dietary methylxanthines, adenosine antagonism or phosphodiesterase inhibition? Metabolism 41: 1233-1241, 1992.
33. Murase T, Nagasawa A, Suzuki J, Hase T and Tokimitsu I: Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obesity 26: 1459-1464, 2002.
34. Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P and Vandermander J: Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 70: 1040-1045, 1999.
35. Yokogoshi H, Mochizuki M and Saitoh K: Theanine-induced reduction of brain serotonin concentration in rats. Biosci Biotech Biochem 62: 816-817, 1998.
36. Yokogoshi H, Kato Y, Sagesaka Y, Matsuura T, Kakuda T and Takeuchi N: Reduction effect of theanine on blood pressure and brain 5-hydroxyindoles in spontaneously hypertensive rats. Biosci Biotech Biochem 59: 615-618, 1995.
37. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ and Baskin DG: Central nervous system control of food intake. Nature 404: 661-671, 2000.
38. Towell A, Muscat R and Willer P: Behavioural microanalysis of the role of dopamine in amphetamine anorexia. Pharmacol Biochem Behav 30: 641-648, 1988.
39. Bina KG and Cincotta AH: Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology 71: 68-78, 2000.